Related Experiment Video

Updated: Feb 18, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

819

MicroRNA-154/ADAM9 axis inhibits the proliferation, migration and invasion of breast cancer cells

Chengwei Qin1,2, Yanming Zhao3, Chunzhi Gong2

  • 1Department of General Surgery, Medical College of Shandong University, Jinan, Shandong 250012, P.R. China.

Oncology Letters
|November 23, 2017
PubMed

Insights

MicroRNA-154 (miR-154) is downregulated in breast cancer, suppressing tumor growth and spread. Restoring miR-154 may offer a new therapeutic strategy for breast cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Breast cancer remains a leading cause of cancer mortality in women.
  • Despite advances in diagnosis and therapy, recurrence and metastasis pose significant treatment challenges.
  • Understanding the molecular mechanisms of breast cancer progression is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the expression, function, and molecular mechanisms of microRNA-154 (miR-154) in human breast cancer.
  • To determine if miR-154 acts as a tumor suppressor in breast cancer.
  • To identify direct molecular targets of miR-154 in breast cancer.

Main Methods:

  • Quantitative real-time PCR to assess miR-154 expression in breast cancer tissues and cell lines.
  • Cell proliferation, migration, and invasion assays to evaluate the functional role of miR-154.
  • Bioinformatic analysis and luciferase reporter assays to identify and validate direct targets of miR-154.

Main Results:

  • miR-154 was significantly downregulated in human breast cancer tissues and cell lines.
  • Restoration of miR-154 expression inhibited breast cancer cell proliferation, migration, and invasion.
  • ADAM metallopeptidase domain 9 (ADAM9) was identified as a direct target of miR-154.

Conclusions:

  • miR-154 functions as a tumor suppressor in breast cancer by targeting ADAM9.
  • The findings suggest that restoring miR-154 expression could be a potential therapeutic strategy for breast cancer.
Keywords:
ADAM metallopeptidase domain 9breast cancergrowthmetastasismicroRNA-154

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K